IRCT2016050220795N3已完成未知
fibrinogen and blood requirement in trauma patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •All trauma patients. Exclusion criteria: Patients having received fibrinogen or cryoprecipitate before operation, Patients with hereditary or acquired coagulopathies and history of allergy to fibrinogen concentrate.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Fibrinolysis and bleeding tendency in the patients with severe trauma.JPRN-UMIN000003110Emergency and Critical Care, Hokkaido University Hospital50
已完成
不适用
Hyperfibrinolysis in moderate to severe traumatic brain injury-related coagulopathyNL-OMON37358Vrije Universiteit Medisch Centrum100
已完成
2 期
Fibrinogen Early In Severe Trauma studYTraumaHaemorrhageCoagulopathyNCT02745041Gold Coast Hospital and Health Service100
Unknown
2 期
Fibrinogen Early In Severe Trauma studY JuniorTraumaHemorrhagePediatricsCoagulopathyNCT03508141Gold Coast Hospital and Health Service44
进行中（未招募）
1 期
se of fibrinogen in the treatment of bleeding in thrombopenic patients after intensive chemotherapy refractory to platelet transfusio- Major patient- Patient with malignant hemopathy requiring intensive chemotherapy, autologous or allogeneic hematopoietic stem cell transplantation- Grade = 1 hemorrhagic symptom according to WHO - WHO classification- Body weight between 38 and 78 kg- Patient presenting with a platelet refractory state defined according to the Corrected Count Increment (CCI)- Patient affiliated to a social security schemeMedDRA version: 21.1Level: LLTClassification code 10066481Term: Hematological malignancySystem Organ Class: 100000004864EUCTR2021-000990-10-FRInstitut de Cancérologie Lucien Neuwirth10